open access
Variant lambda of the severe acute respiratory syndrome coronavirus 2: A serious threat or the beginning of further dangerous mutations
, 4, 35, 4, 1, 6, 6, 78, 910
Affiliations- Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, Warsaw, Poland
- Research Unit, Maria Sklodowska-Curie Bialystok Oncology Center, Bialystok, Poland
- Polish Society of Disaster Medicine, Warsaw, Poland
- International European University, Kiev, Ukraine
- Institute of Outcomes Research, Polonia University, Warsaw, Poland
- Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, United States
- Department of Community Medicine, College of Medicine, University of Ibadan, Oyo State, Nigeria
- Department of Community Medicine, University College Hospital, Ibadan, Oyo State, Nigeria
- Post-graduate School of Occupational Health, Università Cattolica del Sacro Cuore, Rome, Italy
- Health Service Department, Italian State Police, Milan, Italy
open access
Abstract
Abstract
About this articleTitle
Variant lambda of the severe acute respiratory syndrome coronavirus 2: A serious threat or the beginning of further dangerous mutations
Journal
Issue
Article type
Letter to the Editor
Pages
176-177
Published online
2021-10-08
Page views
5564
Article views/downloads
662
DOI
10.5603/CJ.a2021.0121
Pubmed
Bibliographic record
Cardiol J 2022;29(1):176-177.
Authors
Lukasz Szarpak
Ivan Savytskyi
Michal Pruc
Anatolyi Gozhenko
Krzysztof J. Filipiak
Zubaid Rafique
Frank W. Peacock
Olayinka S. Ilesanmi
Francesco Chirico
References (6)- "Tracking SARS-CoV-2 variants". who.int. World Health Organization. Updated frequently. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ (Access: 2 Aug 2021).
- Wink PL, Volpato FC, Monteiro FL, et al. First identification of SARS-CoV-2 Lambda (C.37) variant in Southern Brazil. Infect Control Hosp Epidemiol. 2021 [Epub ahead of print]: 1–7.
- Kimura I, Kosugi Y, Wu J, et al. SARS-CoV-2 Lambda variant exhibits higher infectivity and immune resistance. bioRxiv. 2021; 2021.07.28.454085.
- Acevedo M, Alonso-Palomares L, Bustamante A, et al. Infectivity and immune escape of the new SARS-CoV-2 variant of interest Lambda. medRxiv. 2021; 2021.06.28.21259673.
- Tada T, Zhou H, Dcosta B, et al. SARS-CoV-2 Lambda Variant Remains Susceptible to Neutralization by mRNA Vaccine-elicited Antibodies and Convalescent Serum. bioRxiv. 2021; 2021.07.02.450959.
- Weekly epidemiological update on COVID-19 - 15 June 2021 Edition 44 15 June 2021 | Emergency Situational Update. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---15-june-2021 (Access: 2 August 2021).
